As of 2024-07-27, the Intrinsic Value of Ligand Pharmaceuticals Inc (LGND) is
8.82 USD. This LGND valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 107.14 USD, the upside of Ligand Pharmaceuticals Inc is
%.
The range of the Intrinsic Value is 7.23 - 15.18 USD
LGND Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
7.23 - 15.18 |
8.82 |
-91.8% |
| DCF (Growth 10y) |
3.79 - (0.43) |
2.97 |
-97.2% |
| DCF (EBITDA 5y) |
28.67 - 37.74 |
35.12 |
-67.2% |
| DCF (EBITDA 10y) |
17.77 - 25.75 |
22.65 |
-78.9% |
| Fair Value |
134.11 - 134.11 |
134.11 |
25.18% |
| P/E |
61.17 - 204.71 |
116.32 |
8.6% |
| EV/EBITDA |
42.19 - 52.33 |
47.96 |
-55.2% |
| EPV |
38.17 - 55.65 |
46.91 |
-56.2% |
| DDM - Stable |
52.90 - 274.62 |
163.76 |
52.8% |
| DDM - Multi |
20.76 - 86.57 |
33.81 |
-68.4% |
LGND Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,924.23 |
| Beta |
1.49 |
| Outstanding shares (mil) |
17.96 |
| Enterprise Value (mil) |
1,874.14 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.43% |
| Cost of Debt |
5.50% |
| WACC |
8.43% |